|
|
Article: Targeted Genetics Corporation Announces Strategic Alliance.
- Article from:
- PR Newswire
- Article date:
- June 10, 1999
CopyrightCOPYRIGHT 1999 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
- Targeted Genetics to Receive Exclusive Rights to Seminal
AAV Manufacturing Patent from Alkermes, Inc. -
SEATTLE, June 10 /PRNewswire/ -- Targeted Genetics Corporation (Nasdaq: TGEN) today announced an alliance with Alkermes, Inc. (Nasdaq: ALKS) that provides Targeted Genetics with exclusive rights to a seminal patent for the manufacture of Adeno-Associated Viral (AAV) vectors.
Under the terms of the agreement, Targeted Genetics will issue 500,000 shares of common stock as payment for an up-front license fee to Alkermes for exclusive rights to the issued patent and related pending patent applications. In addition, Targeted Genetics will issue to ...